Lemaitre Vascular INC Schedule 13G passive stakes

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting beneficial ownership of 5.15% of LeMaitre Vascular, Inc. common stock.

George W. LeMaitre has filed a Schedule 13G, reporting beneficial ownership of 1,465,235 shares of LeMaitre Vascular, Inc. common stock, representing 6.4% of the outstanding shares.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in LeMaitre Vascular Inc. following an internal corporate realignment.

Conestoga Capital Advisors has reported a beneficial ownership of 6.73% in Lemaitre Vascular Inc., holding over 1.5 million shares as of December 31, 2025.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., reported beneficial ownership of 7.43% of the company's common stock as of September 30, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 13.8% of Lemaitre Vascular Inc.'s common stock as of March 31, 2025.

George W. LeMaitre, a U.S. citizen, has filed an amendment to his Schedule 13G, disclosing a beneficial ownership of 8.5% of LeMaitre Vascular Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a significant beneficial ownership of 17.4% in Lemaitre Vascular Inc. as of December 31, 2024.

Copeland Capital Management has disclosed a 5.21% ownership stake in LeMaitre Vascular Inc. as of December 31, 2024.

Conestoga Capital Advisors and its affiliated funds have filed an updated Schedule 13G, disclosing a combined beneficial ownership of 8.12% and 5.4% respectively, in LeMaitre Vascular Inc.'s common stock as of December 31, 2024.